The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk of recurrence.
Hicks
David G
DG
Clarient Inc, Aliso Veijo, California, USA.
Janarthanan
Bagi R
BR
Vardarajan
Ramya
R
Kulkarni
Swati A
SA
Khoury
Thaer
T
Dim
Daniel
D
Budd
G Thomas
GT
Yoder
Brian J
BJ
Tubbs
Raymond
R
Schreeder
Marshall T
MT
Estopinal
Noel C
NC
Beck
Rodney A
RA
Wang
Yanling
Y
Ring
Brian Z
BZ
Seitz
Robert S
RS
Ross
Douglas T
DT
D014408:Biomarkers, Tumor / Q000096:biosynthesis*; D001943:Breast Neoplasms / Q000201:enzymology* / Q000473:pathology; D015331:Cohort Studies; D005260:Female; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000201:enzymology* / Q000473:pathology; D009367:Neoplasm Staging; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000096:biosynthesis*; D012307:Risk Factors; D012359:tRNA Methyltransferases / Q000096:biosynthesis*
D014408:Biomarkers, Tumor; D018719:Erb-b2 Receptor Tyrosine Kinases; D012359:tRNA Methyltransferases